期刊文献+

骨保护素与冠心病关系的探讨 被引量:6

Study on relationship between serum level of osteoprotegerin and coronary heart disease
原文传递
导出
摘要 目的 探讨血清骨保护素 (osteoprotegerin ,OPG)水平与冠心病的关系。方法  90例住院患者 ,根据冠状动脉造影的结果分为冠心病组 6 4例及对照组 2 6例 ,采用ELISA法测定OPG水平与吸烟史、糖尿病、高血压、年龄、性别、体重指数、血钙、血脂各指标之间的关系。结果 冠心病组患者血清中OPG水平明显高于对照组 ,P <0 0 5。OPG水平随冠状动脉病变支数的增加而升高 (P <0 0 0 1)。冠状动脉造影正常或内腔轻度不规则、单支病变、2支病变、3支病变的患者 ,其血清中OPG水平分别为 ( 0 10 4± 0 0 35 ) ,( 0 111± 0 0 37) ,( 0 130± 0 0 84 ) ,( 0 16 9± 0 0 77) μg/L。 结论OPG水平升高与冠心病密切相关 ,OPG浓度越高 ,冠状动脉病变越严重。 Objective To study the relationship of serum osteoprotegerin and coronary heart disease(CHD). Methods According angiography,sixty four CHD patients were enrolled as CHD group and twenty six non CHD patients as control group, CHD group was divided into single ,double ,triple vessel groups.The serum level of osteoprotegerin was measured by ELISA in all subjects who had received coronary angiography (CAG).The relations between OPG and cigarette smoking,diabetes,hypertension,age, sex, body mass index, Ca 2+ ,blood lipid were analyzed. Results The level of serum OPG was significantly higher in patients with CHD than in the control group (0 1376±0 0614 μg/L vs 0 1042±0 0354 μg/L, P <0 05). As the stenosis vessels increased, the OPG levels also increased ( P <0 001).The serum OPG levels of no stenosis, single ,double , triple vessel group were 0 104±0 035 μg/L,0 111±0 037 μg/L, 0 13±0 084 μg/L,0 169±0 077 μg/L respectively. Conclusion OPG may be directly related to the initiation and development of coronary lesions. The higher level of serum osteoprotegerin, the greater the degress of coronary arteries lesions would be.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2004年第6期501-503,共3页 Chinese Journal of Cardiology
关键词 骨保护素 冠心病 冠状动脉造影 ELISA法 Coronary disease Receptors, tumor necrosis facotor Osteoprotegerin
  • 相关文献

参考文献10

  • 1Dhore CR,Cleutjens JP,Lutgens E,et al.Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques[].Arteriosclerosis Thrombosis and Vascular Biology.2001
  • 2Browner WS,Lui LY,Cummings SR.Association of serum osteoprotegerin levels with diabetes,stroke,bone density, fractures, and mortality in elderly women[].The Journal of Clinical Endocrinology.2001
  • 3Ross R: Atherosclerosis-An inflammatory disease. The New England Journal of Medicine . 1999
  • 4Simonet WS,Lacey DL,Dunstan CR,et al.Osteoprotegerin:anovel secreted protein involved in the regulation of bone density[].Cell.1997
  • 5Yano K,Tsuda E,Washida N,et al.Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis[].Journal of Bone and Mineral Research.1999
  • 6Yun TJ,Chaudhary PM,Shu GL,et al.OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is upregulated by ligating CD40[].J Immunol.1998
  • 7Hofbauer LC,Khosla S,Dunstan CR,et al.The role of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption[].Journal of Bone and Mineral Research.2000
  • 8Bucay N,Sarosi I,Dunstan CR,et al.Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification[].Genes and Development.1998
  • 9Min H,Morony S,Sarosi I,et al.Osteoprotegerin reverses osteoporosis by inhibiting endosteal osteoclasts and prevents vascular calcification by blocking a process resembling osteoclastogenesis[].The Journal of Experimental Medicine.2000
  • 10Malyankar UM,Scatena M,Suchland KL,et al.Osteoprotegerin is an alpa vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells[].Journal of Biological Chemistry.2000

同被引文献73

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部